. .
Ett nivå opp
   
NEVR3010  
. .
 

Til topp


Til topp


 

Emosjoner og emosjonelle forstyrrelser

The subjective feelings known as emotions are an essential feature of normal human experience; moreover, some of the most devastating psychiatric problems involve emotional (affective) disorders. Although everyday emotions are as varied as happiness, surprise, anger, feer, and sadness, some characteristics are common to all of them. Thus, all emotions are expressed through both physiological changes and stereotyped motor responses, especially of the facial muscles. These responses accompany subjective experiences that are not easily described, but which are much the same in all human cultures. Expression of the emotions is closely tied to the autonomic nervous system and therefore entails the activity of certain brainstem nuclei, the hypothalamus, and the amygdala, as well as the preganglionic neurons in the spinal cord, the autonomic ganglia and peripheral effectors. The centers that coordinate emotional responses have been grouped under the rubric of the limbic system. At the cortical level, the two hemispheres differ in their governance of the emotions, the right hemisphere being more critically involved than the left - yet another example of hemispheric specialization.



AFFECTIVE DISORDERS

Whereas some degree of disordered emotion is present in virtually all psychiatric problems, in affective (mood) disorders, the essence of the disease is an abnormal regulation of the feelings of sadness and happiness that are part of everyone's life. The most severe of these afflictions are major depression and manic depression. (Manic depression is also called bipolar disorder, since such pasients experience alternating episodes of depression and euphoria.) Depression, the most common of the major psychiatric disorders, has a lifetime prevalence of about 5 - 8% in the population; if one includes bipolar disorder, the lifetime prevalence of affective disorders rises to nearly 10%! For clinical purposes, depression (as distinct from bereavement or neurotic unhappiness) is defined by a set of standard criteria, one or more of which must be present to tender the diagnosis. In addition to an abnormal sense of sadness, despair, and bleak feelings about the future (depression itself), these criteria include disordered eating and weight control; disordered sleeping (insomnia or hypersomnia); and diminished sexual interest.

  The overwhelming quality of major depression has been compellingly described by pasient/authors such as William Styron, and by afflicted psychologists such as Kay Jamison. But the depressed patient's profound sense of despair has been nowhere better expressed than by Abraham Lincoln, who during a period of depression said:

"I am now the most miserable man living. If what I feel were equally distributed to the whole human family, there would not be one cheerful face on earth. Whether I shall ever be better, I cannot tell; I awfully forbode I shall not. To remain as I am is impossible. I must die or be better, it appears to me."

Indeed, about half the suicides in this country occur in individuals with clinical depression.
In earlier times, depression and mania were considered disorders that arose from circumstances or the neurotic inability to cope with normal problems. It is now universally accepted that these conditions are neurobiological disorders.

Among the strongest lines of evidence for this consensus are studies of the inheritance of these diseases. For example, the concordance of affective disorders is very high in monozygotic compared to dizygotic twins. Despite evidence for a genetic pre disposition to affective disorders, the cause remains unknown. The efficacy of a large number of drugs that influence catecholaminergic and serotonergic neurotransmission strongly implies that the basis of the disorder is ultimately neurochemical. The majority of patients (about 70%) can be effectively treated with one of a variety of drugs, which are among the most widely prescribed agents worldwide.
Pharmaceutical companies have now succeeded in synthesizing drugs that selectively block the uptake of serotonin without affecting the uptake of other neurotransmitters.

Teksten er hentet fra boken "Neuroscience", Purves et al., 1997. Sinauer forlag

 
  
Redaktør: Instituttleder , Kontaktadresse: webmaster@phys.ntnu.no
Sist oppdatert: 09.10.2004